Drawing for CAPTYANE

USPTO serial 74296771

CAPTYANE

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
—
Examiner
MCLEOD, LINDA K.
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CAPTYANE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jeffrey C. Katz

JEFFREY C KATZ DAVIS & GILBERT1740 BROADWAYNEW YORK, NY 10019UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
003eye cream and face creamABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 15, 1993ABN1ABANDONMENT - EXPRESS MAILED—
Mar 2, 1993NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 8, 1992PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 6, 1992NPUBNOTICE OF PUBLICATION—
Oct 5, 1992CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 1, 1992DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance